Complete Guide to Medical Device Clinical Investigations under EU MDR 2017/745



Frequently Asked Questions

Whether the enrollment status of trial subject should be informed to CLA?

Yes. The status of enrolment of the trial subjects shall be intimated to the CLA on quarterly basis or as appropriate as per the duration of treatment in accordance with the approved clinical trial protocol, whichever is earlier. Further, six monthly status report of each clinical trial, as to whether it is ongoing, completed or terminated, shall be submitted in SUGAM portal. In case of termination of any clinical trial the detailed reasons for such termination shall be communicated to CLA.

Related Articles

Drug |
End-to-End Clinical Research Services: How a CRO Supports Drug Development Process from Phase I to Market

Clinical Research Services support every stage of Drug development, from study planning and trial management to regulatory submissions and post-marketing activities. Contract Research Organisations bring to the table their expertise in Clinical Trial execution, biostatistics and data management, regulatory affairs, patient recruitment, and pharmacovigilance. These services help sponsors conduct clinical research timely and efficiently while

Clinical Trials |
Medical Devices |
Choosing the Right CRO for Medical Device Clinical Trials

Short Summary A Medical Device CRO provides specialised support for planning, managing, and conducting clinical investigations for Medical Devices. Choosing a CRO for medical device clinical trials helps improve study quality, manage challenges effectively, and support successful trial completion. Strong regulatory expertise, Good Clinical Practice compliance, and quality management systems help ensure that clinical investigations

Biologicals |
Clinical Trials |
Diagnostic Kits |
Drug |
Medical Devices |
Understanding Informed Consent in Clinical Research

Informed consent in clinical research is a cornerstone of ethical regulatory compliance. It ensures that participants voluntarily decide whether to take part in a study after receiving adequate information about its purpose, procedures, risks, benefits, and alternatives. It is an ongoing process that promotes transparency, protects participants’ rights, and supports autonomous decision-making. Introduction Informed consent


*All the above fields are mandatory
contact us 2
Enquire now